We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Catalent Acquires R.P. Scherer Eberbach

News   Mar 02, 2012

 
Catalent Acquires R.P. Scherer Eberbach
 
 
 

RELATED ARTICLES

Scientists Breach Brain Barriers To Tackle Tumors

News

Yale researchers have discovered a novel way to evade the brain’s natural defenses by slipping immune system “rescuers” through its drainage system.

READ MORE

Team Develops New Nanoparticle Drug To Treat Aggressive Breast Cancer

News

Researchers have engineered and tested a new therapeutic nanoparticle platform to deliver the drug paclitaxel to treat triple-negative breast cancer.

READ MORE

Egg Yolks Help Researchers Crack New Insulin Compound

News

In a promising discovery that could improve the clinical delivery of insulin for people living with diabetes, scientists have developed a non-fibrillating form of human insulin.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE